UK GLP-1 Market Report: What You'll Actually Pay for Wegovy & Mounjaro

Summary of Charts: Prices, Weight Loss, Delivery & Trustpilot (UK GLP-1 Market Overview)

This visual report presents a clear and up-to-date overview of the UK market for GLP-1 medications (Wegovy & Mounjaro). The analysis is based on regularly updated data from licensed UK online clinics and pharmacies, as well as official clinical study results.

Price Distribution Across Providers (Wegovy & Mounjaro)

The first chart shows the monthly price distribution for Wegovy and Mounjaro in the UK private market. Prices are grouped into £50 intervals to illustrate how many providers fall within each price range.

What the chart shows:

• The price distribution for each dose
• Average differences between providers
• Price clusters where most providers fall
• 25th percentile, average and 75th percentile as key reference points

How to use this chart:

Toggle between semaglutide and tirzepatide, filter by dose if needed, and hover over the bars to see the exact £50 buckets. The dotted reference lines connect the 25th percentile, mean and 75th percentile cards so you can instantly understand how a provider's quote compares to the wider UK market.

This helps users clearly understand the current price landscape across the UK GLP-1 market.

It also allows quick comparison between providers to identify both typical and outlier pricing.

Weekly Weight Loss (Cumulative, kg)

This chart shows the expected cumulative weight loss over 12 weeks or 12 months for Wegovy and Mounjaro based on clinical trial data. The curves highlight how average weight loss progresses over time.

What the chart shows:

• The difference in weight-loss trajectories between Wegovy and Mounjaro
• Faster early weight loss with Mounjaro
• Long-term trends over weekly and monthly views
• A clear visual comparison of clinical effectiveness

How to use this chart:

Toggle between Weeks and Months, and switch between Wegovy, Mounjaro, or both. Hover to see exact cumulative values at each time point.

This gives users a realistic expectation of how weight loss may progress when using GLP-1 treatment.

It also helps highlight the clinical difference between semaglutide and tirzepatide at various timepoints.

UK GLP-1 Shipping: Which Providers Offer Free or Fast Delivery?

This chart shows how UK GLP-1 providers structure their delivery options, ranging from free shipping to next-day delivery. It helps users understand the convenience offered across the market.

What the chart shows:

• How many providers offer free delivery
• Order thresholds for free delivery (£30 / £50)
• Standard vs tracked shipping options
• Availability of next-day delivery
• Providers that do not specify delivery information

How to use this chart:

Hover over any segment to see the exact percentage and number of providers offering that delivery type.

Click on any legend item (for example Free, Free ≥ 30, Tracked/Standard, NextDay) to open a modal listing of all providers that offer that specific delivery option. Each provider appears as a pill-style tag inside the modal, making it easy to scan and compare.

This helps users understand which delivery options are most common across UK providers.

It also highlights how shipping policies can influence convenience and overall cost.

Trustpilot Ratings Distribution

This histogram shows the distribution of public Trustpilot ratings among providers offering GLP-1 medications in the UK.

Key insights:

• Most providers fall within the 4.0 – 4.5 rating range.
• The overall average rating is roughly 4.2+.
• Only a small number of providers have ratings below 3.5.
• Good reviews strongly influence consumer decisions - according to the CMA, more than half of UK adults read reviews before making a purchase.

How to use this chart:

Hover over each peak or bar to see how many providers hold that exact Trustpilot score. This helps identify both top-rated and lower-rated providers.

It helps users assess service quality and patient experience for each provider, enabling more informed choices.

Conclusion

These four charts provide a clear and balanced overview of the UK market for GLP-1 medications - combining real provider pricing, clinical performance data, delivery options, and service reputation (Trustpilot).

The report is designed to help users understand the market, make informed decisions, and compare providers transparently.

Trusted Medical References

• New England Journal of Medicine – STEP Clinical Trial: Semaglutide for Weight Management
• New England Journal of Medicine – SURMOUNT Clinical Trial: Tirzepatide for Weight Management
• NICE Guidance NG246 – Obesity: Identification, Assessment and Management (UK)
• Trustpilot – Public Provider Ratings for UK Online Pharmacies